Sign in
GCAN Stock Price, Chart, Stats & News
The Greater Cannabis Company, Inc.
Save
The Greater Cannabis Company, Inc. (GCAN) does not currently pay a dividend.
348,032
Market cap
–
Current P/E
–
Forward P/E
GCAN chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Medical - Pharmaceuticals
Industry
The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson’s disease, Alzheimer’s disease, and other neuropsychiatric disorders.
Similar securities
Based on sector and market capitalization
Report issue